Market Research Reports - Ken Research Robotic Assisted Surgical Devices (Rasd) Market

What is the Scenario of Global Robotic Surgery market?
Rise in need for faster recovery, reduced pain and discomfort has led to growth of global
robotic surgery market in the past few years. Owing to rising adoption of minimally invasive
surgeries, the market for global robotic surgery grew at a healthy CAGR of ~% during 2012-2017
from USD ~ million in 2012 to ~ million in 2017. During the concerned period, market grew
predominantly due to increase in sales of da Vinci systems across the world and surgical
procedures performed by them. The number of installed da Vinci systems grew from ~ in 2012
to ~ in 2017 and the number of surgical procedures conducted inclined from 359,000 in 2011 to
753,000 in 2016.
The market growth was also aided due to the commercial launch of several new systems in the
US and/or Europe and other territories. Some of the surgical robots approved and commercially
launched included MAKO, OMNIBotics, ARTAS, ROSA, NAVIO, TSoultion One, Neuromate,
Mazor X and Renaissance for a variety of indication such as spine and brain surgeries,
total/partial knee and total hip arthroplasty and hair transplant. Over ~ spine and brain
surgeries and more than ~ total/partial knee and total hip replacement procedures were
performed using surgical robots in 2017.
International expansion has been slow over the past decade due to the fact that the majority of
these companies are US based. Most companies have been focused on gaining regulatory
approvals from the FDA and subsequently market the product aggressively before launching the
systems elsewhere in the world. The process of individually gaining approval in various
countries has slowed the growth of the entire surgical robotics industry. Additionally, all
robotics companies face the challenge of convincing hospitals to purchase systems that are
usually priced in excess of USD 1 million.
Which Segments are doing Well in Global Robotic Surgery Market?
North America accounted for the highest market share (~ %) in 2017, in terms of revenue. This
was primarily due to high standards of healthcare infrastructure, high patient awareness levels
and high healthcare expenditure by consumer and government as compared to other regions of
the world.
Over ~ % of the North American revenue was due to high adoption of robotic surgery systems
in the US. The US market for surgical robotics has been driven by the financial capability of
hospitals to invest in these systems, strategic collaboration with insurance players, rising
patient acceptance owing to superior post-operative outcomes, and general awareness about
computer-assisted surgeries.